Bo Mu

728 total citations
26 papers, 562 citations indexed

About

Bo Mu is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Bo Mu has authored 26 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Bo Mu's work include RNA modifications and cancer (3 papers), Synthesis and biological activity (2 papers) and Ferroptosis and cancer prognosis (2 papers). Bo Mu is often cited by papers focused on RNA modifications and cancer (3 papers), Synthesis and biological activity (2 papers) and Ferroptosis and cancer prognosis (2 papers). Bo Mu collaborates with scholars based in China and France. Bo Mu's co-authors include Shi H, Yuquan Wei, Lina Zhou, Zhiyong Li, Wen Yuan, Fei Leng, Yongsheng Wang, Wei Wang, Yang Li and Yu Ma and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Bo Mu

24 papers receiving 557 citations

Peers

Bo Mu

ONCOL

IMMUN

PRM

Xiping Xin Canada

Jiazheng Sun China

Tian Ma China

P Yue United States

Yong-Nyun Kim South Korea

Chang Xu China

Esha Madan United States

Yonggang Wang China

Xinling Ren China

Giacomo Canesin United States

Xiping Xin Canada

Bo Mu

360 ×1.1

243 ×1.4

ONCOL

153 ×1.0

105 ×1.1

IMMUN

43 ×0.7

PRM

Citations per year, relative to Bo Mu Bo Mu (= 1×) peers Xiping Xin

Countries citing papers authored by Bo Mu

Since Specialization

Citations

This map shows the geographic impact of Bo Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Mu more than expected).

Fields of papers citing papers by Bo Mu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Mu. The network helps show where Bo Mu may publish in the future.

Co-authorship network of co-authors of Bo Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Mu. A scholar is included among the top collaborators of Bo Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Mu. Bo Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Rong, Min Zhang, Wen Lu, et al.. (2025). Integrated multi-Omics and network toxicology elucidate the multi-target mechanisms of environmental hormones in driving hepatocellular carcinoma. Ecotoxicology and Environmental Safety. 309. 119519–119519.

Mu, Bo, et al.. (2025). Polyurethane@CeO2 Nanozyme Core–Shell Fibrous Membranes for Enhanced Wound Healing via Balanced Redox Modulation. Catalysts. 15(7). 617–617. 1 indexed citations

Shang, Yi, et al.. (2024). 1-DNJ Alleviates Obesity-Induced Testicular Inflammation in Mice Model by Inhibiting IKKβ/ NF-kB Pathway. Reproductive Sciences. 31(7). 2103–2113. 6 indexed citations

Chen, Yahui, et al.. (2024). ASB6 as an Independent Prognostic Biomarker for Colorectal Cancer Progression Involves Lymphatic Invasion and Immune Infiltration. Journal of Cancer. 15(9). 2712–2730. 1 indexed citations

Chen, Yan, Jiasheng Chen, Bo Mu, & Shi H. (2024). A Design of Quartz Crystal Microbalance Immune Sensing System for Ovarian Cancer Tumor Markers Detection. 538–542.

Zhang, Yun, Jiao Yan, Anjie Xia, et al.. (2023). Discovery of a novel pyroptosis inhibitor acting though modulating glutathionylation to suppress NLRP3-related signal pathway. International Immunopharmacology. 127. 111314–111314. 5 indexed citations

Pu, Yu, et al.. (2022). Effect of F11R Gene Knockdown on Malignant Biological Behaviors of Pancreatic Cancer Cells. Journal of Oncology. 2022. 1–8. 2 indexed citations

Yang, Wei, Bo Mu, Jing You, et al.. (2022). Non-classical ferroptosis inhibition by a small molecule targeting PHB2. Nature Communications. 13(1). 7473–7473. 41 indexed citations

Yan, Jiao, Bo Mu, Yun Zhang, et al.. (2022). Discovery of a novel and potent inhibitor with differential species-specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis. European Journal of Medicinal Chemistry. 232. 114194–114194. 43 indexed citations

10.

Chen, Pei, Ming Wu, Falu Wang, et al.. (2022). Discovery of a potent and highly selective inhibitor of ataxia telangiectasia mutated and Rad3-Related (ATR) kinase: Structural activity relationship and antitumor activity both in vitro and in vivo. European Journal of Medicinal Chemistry. 232. 114187–114187. 15 indexed citations

11.

Zhang, Yun, Anjie Xia, Shiyu Zhang, et al.. (2021). Discovery of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 41. 127881–127881. 5 indexed citations

12.

Pu, Yu, et al.. (2020). IL10-modified Human Mesenchymal Stem Cells inhibit Pancreatic Cancer growth through Angiogenesis Inhibition. Journal of Cancer. 11(18). 5345–5352. 16 indexed citations

13.

Zhao, Jia, et al.. (2019). The Effects and Mechanisms by which Saikosaponin-D Enhances the Sensitivity of Human Non-small Cell Lung Cancer Cells to Gefitinib. Journal of Cancer. 10(26). 6666–6672. 18 indexed citations

14.

Jiang, Hai, Ying Ma, Qin Gao, et al.. (2014). Association between DRD2/ANKK1 TaqIA polymorphism and common illicit drug dependence: Evidence from a meta-analysis. Human Immunology. 76(1). 42–51. 28 indexed citations

15.

Mu, Bo, et al.. (2013). Screening of Multiple Myeloma by Polyclonal Rabbit Anti-Human Plasmacytoma Cell Immunoglobulin. PLoS ONE. 8(4). e59117–e59117. 2 indexed citations

16.

Zhou, Yan, Jing He, Lantu Gou, et al.. (2012). Expression of CD40 and growth-inhibitory activity of CD40 agonist in ovarian carcinoma cells. Cancer Immunology Immunotherapy. 61(10). 1735–1743. 14 indexed citations

17.

Yao, Yuqin, Jiong Li, Aiping Tong, et al.. (2011). Proteomic analysis of the interleukin‐4 (IL‐4) response in hepatitis B virus‐positive human hepatocelluar carcinoma cell line HepG2.2.15. Electrophoresis. 32(15). 2004–2012. 12 indexed citations

18.

Yuan, Wen, Zhiyong Li, Lina Zhou, et al.. (2010). Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model. Cancer Science. 101(11). 2325–2332. 130 indexed citations

19.

Mu, Bo, Lantu Gou, Yuqin Yao, et al.. (2010). Polyclonal rabbit anti-murine plasmacytoma cell globulins induce myeloma cells apoptosis and inhibit tumour growth in mice. APOPTOSIS. 16(4). 370–381. 6 indexed citations

20.

H, Shi, Dan Li, Yongsheng Wang, et al.. (2010). Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice. Cancer Science. 101(6). 1447–1453. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact